Gallo, G.; Nalli, G.; Baratta, F.; Desideri, G.; Savoia, C.
Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention. Int. J. Mol. Sci. 2025, 26, 8081.
https://doi.org/10.3390/ijms26168081
AMA Style
Gallo G, Nalli G, Baratta F, Desideri G, Savoia C.
Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention. International Journal of Molecular Sciences. 2025; 26(16):8081.
https://doi.org/10.3390/ijms26168081
Chicago/Turabian Style
Gallo, Giovanna, Gabriele Nalli, Francesco Baratta, Giovambattista Desideri, and Carmine Savoia.
2025. "Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention" International Journal of Molecular Sciences 26, no. 16: 8081.
https://doi.org/10.3390/ijms26168081
APA Style
Gallo, G., Nalli, G., Baratta, F., Desideri, G., & Savoia, C.
(2025). Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention. International Journal of Molecular Sciences, 26(16), 8081.
https://doi.org/10.3390/ijms26168081